The DOI matches its Crossref record; 473 of the 473 references it cites were found in a registry or an index.
Adenosine and Brain Function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Stein, E., Zou, Y., Poo, M.-M., & Tessier-Lavigne, M. (2001) · Science · doi:10.1126/science.1059391 · Cited by 242
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
Self-citationInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationLong-Term Potentiation and Memory
LYNCH, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 1,991
The Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Self-citationCalker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness
Porkka-Heiskanen, T., Strecker, R. E., Thakkar, M., Bjørkum, A. A., Greene, R. W., & McCarley, R. W. (1997) · Science · doi:10.1126/science.276.5316.1265 · Cited by 1,252
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Jasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Self-citationSATTIN, A., & RALL, T. W. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15197-3 · Cited by 892
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures
Bengzon, J., Kokaia, Z., Elmér, E., Nanobashvili, A., Kokaia, M., & Lindvall, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10432 · Cited by 782
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
Latini, S., & Pedata, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00607.x · Cited by 777
The role of adenosine and its nucleotides in central synaptic transmission
Phillis, J. W., & Wu, P. H. (1981) · Progress in Neurobiology · doi:10.1016/0301-0082(81)90014-9 · Cited by 764
Lüscher, C., Jan, L. Y., Stoffel, M., Malenka, R. C., & Nicoll, R. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80381-5 · Cited by 758
Klotz, K.-N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B. B., & Lohse, M. J. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005131 · Cited by 723
Self-citationOlsson, R. A., & Pearson, J. D. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.3.761 · Cited by 683
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 658
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 650
How does adenosine inhibit transmitter release?
FREDHOLM, B., & DUNWIDDIE, T. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90194-0 · Cited by 641
Self-citationCunha, R. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00034-6 · Cited by 631
Self-citationThe Physiological Role of Adenosine In The Central Nervous System
Dunwiddie, T. V. (1985) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60556-5 · Cited by 623
Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen, J.-F., Xu, K., Petzer, J. P., Staal, R., Xu, Y.-H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N., & Schwarzschild, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 606
Self-citationDimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
Structure and function of adenosine receptors and their genes
Fredholm, B. B., Arslan, G., Halldner, L., Kull, B., Schulte, G., & Wasserman, W. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000313 · Cited by 583
Self-citationTissue distribution of adenosine receptor mRNAs in the rat
Dixon, A. K., Gubitz, A. K., Sirinathsinghji, D. J. S., Richardson, P. J., & Freeman, T. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15561.x · Cited by 565
A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J.-F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557
Self-citationPhosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Self-citationYung, K. K. L., Bolam, J. P., Smith, A. D., Hersch, S. M., Ciliax, B. J., & Levey, A. I. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00536-e · Cited by 542
Schiffmann, S. N., Jacobs, O., & Vanderhaeghen, J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08257.x · Cited by 530
Purinergic Signalling: ATP Release
Bodin, P., & Burnstock, G. (2001) · Neurochemical Research · doi:10.1023/a:1012388618693 · Cited by 521
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Self-citationHaskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Self-citationAdenosine receptors in the nervous system: pathophysiological implications
Ribeiro, J. A., Sebastião, A. M., & de Mendonça, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00155-7 · Cited by 509
Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., Escorihuela, R. M., Fernández-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 505
Self-citationCha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Storage and Release of ATP from Astrocytes in Culture
Coco, S., Calegari, F., Pravettoni, E., Pozzi, D., Taverna, E., Rosa, P., Matteoli, M., & Verderio, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209454200 · Cited by 490
Hersch, S., Ciliax, B., Gutekunst, C., Rees, H., Heilman, C., Yung, K., Bolam, J., Ince, E., Yi, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05222.1995 · Cited by 483
Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 483
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 482
Thompson, S. M., Haas, H. L., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019168 · Cited by 480
Faure, M., Voyno-Yasenetskaya, T. A., & Bourne, H. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37127-2 · Cited by 476
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
During, M. J., & Spencer, D. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320504 · Cited by 476
Excitotoxic injury of the neostriatum: a model for Huntington's disease
DiFiglia, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90111-m · Cited by 471
Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.
Cronstein, B. N., Kramer, S. B., Weissmann, G., & Hirschhorn, R. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.4.1160 · Cited by 464
Cavazos, J., Das, I., & Sutula, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03106.1994 · Cited by 457
Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Neuroprotective role of adenosine in cerebral ischaemia
Rudolphi, K. A., Schubert, P., Parkinson, F. E., & Fredholm, B. B. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90141-r · Cited by 444
Self-citationAdenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K., Fuxe, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432
Liu, F., Wan, Q., Pristupa, Z. B., Yu, X.-M., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 431
Fredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430
Self-citationAdenosine and the concept of ‘retaliatory metabolites’
Newby, A. C. (1984) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(84)90176-2 · Cited by 428
Glial Cell Inhibition of Neurons by Release of ATP
Newman, E. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01659.2003 · Cited by 426
Molecular cloning and characterization of the human A3 adenosine receptor.
Salvatore, C. A., Jacobson, M. A., Taylor, H. E., Linden, J., & Johnson, R. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10365 · Cited by 424
Hagberg, H., Andersson, P., Lacarewicz, J., Jacobson, I., Butcher, S., & Sandberg, M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03419.x · Cited by 422
Dunwiddie, T. V., Diao, L., & Proctor, W. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07673.1997 · Cited by 413
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409
Self-citationDetermination of Brain Interstitial Concentrations by Microdialysis
Benveniste, H., Hansen, A. J., & Ottosen, N. S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07252.x · Cited by 401
Trophic effects of purines in neurons and glial cells
Rathbone, M. P., Middlemiss, P. J., Gysbers, J. W., Andrew, C., Herman, M. A. R., Reed, J. K., Ciccarelli, R., Di Iorio, P., & Caciagli, F. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00017-9 · Cited by 398
Debating controversies can enhance creativity
Liu, S. V. (2000) · Nature · doi:10.1038/35001232 · Cited by 392
Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system
Rosin, D. L., Robeva, A., Woodard, R. L., Guyenet, P. G., & Linden, J. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981116)401:2<163::aid-cne2>3.0.co;2-d · Cited by 389
Cronstein, B. N., Daguma, L., Nichols, D., Hutchison, A. J., & Williams, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114547 · Cited by 376
Scanziani, M., Capogna, M., Gähwiler, B. H., & Thompson, S. M. (1992) · Neuron · doi:10.1016/0896-6273(92)90244-8 · Cited by 369
Ferré, S., Karcz-Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxe, K., Goldberg, S. R., Lluis, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365
Adenosine-dopamine interactions in the brain
Ferré, S., Fuxe, K., von Euler, G., Johansson, B., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 364
Self-citationPoucher, S. M., Keddie, J. R., Singh, P., Stoggall, S. M., Caulkett, P. W. R., Jones, G., & Collis, M. G. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15923.x · Cited by 363
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357
Strecker, R. E., Morairty, S., Thakkar, M. M., Porkka-Heiskanen, T., Basheer, R., Dauphin, L. J., Rainnie, D. G., Portas, C. M., Greene, R. W., & McCarley, R. W. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00258-8 · Cited by 357
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. (1998) · Annals of Neurology · doi:10.1002/ana.410430415 · Cited by 354
Adenosine in the spinal cord and periphery: release and regulation of pain
Sawynok, J., & Liu, X. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00050-9 · Cited by 353
Adenosine Inhibition of Mesopontine Cholinergic Neurons: Implications for EEG Arousal
Rainnie, D. G., Grunze, H. C. R., McCarley, R. W., & Greene, R. W. (1994) · Science · doi:10.1126/science.8303279 · Cited by 340
Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338
Reppert, S. M., Weaver, D. R., Stehle, J. H., & Rivkees, S. A. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1037 · Cited by 336
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334
Normal aging: regionally specific changes in hippocampal synaptic transmission
Barnes, C. A. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90029-9 · Cited by 332
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease
Bara-Jimenez, W., Sherzai, A., Dimitrova, T., Favit, A., Bibbiani, F., Gillespie, M., Morris, M. J., Mouradian, M. M., & Chase, T. N. (2003) · Neurology · doi:10.1212/01.wnl.0000073136.00548.d4 · Cited by 327
NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release
Mody, I. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89070-7 · Cited by 324
Fastbom, J., Pazos, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)92961-7 · Cited by 322
Pharmacology of adenosine A2A receptors
Ongini, E., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)80010-1 · Cited by 321
Self-citationIntercellular calcium signaling mediated by point-source burst release of ATP
Arcuino, G., Lin, J. H.-C., Takano, T., Liu, C., Jiang, L., Gao, Q., Kang, J., & Nedergaard, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152588599 · Cited by 314
Yacoubi, M. E., Ledent, C., Ménard, J., Parmentier, M., Costentin, J., & Vaugeois, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703170 · Cited by 307
Self-citationAdenosine A2 receptor-mediated excitatory actions on the nervous system
SEBASTIAO, A. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00035-6 · Cited by 304
Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells
Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., & Jacobson, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4429 · Cited by 303
Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD
Hauser, R. A., Hubble, J. P., Truong, D. D., & the Istradefylline US-001 Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000081227.84197.0b · Cited by 300
Cyclic Nucleotides in the Nervous System
Daly, J. (1977) · Springer eBooks · doi:10.1007/978-1-4613-4127-7 · Cited by 294
Rudolphi, K. A., & Schubert, P. (1995) · Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology · doi:10.1007/978-1-4615-2011-5_43 · Cited by 294
Pharmacologic analysis of drug-receptor interaction
Netter, K. J. (1994) · Toxicology · doi:10.1016/0300-483x(94)90086-8 · Cited by 284
Fuxe, K., Ferré, S., Zoli, M., & Agnati, L. F. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00049-0 · Cited by 280
Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype
Stehle, J. H. (1992) · Molecular Endocrinology · doi:10.1210/me.6.3.384 · Cited by 275
Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy
Tasch, E., Cendes, F., Li, L. M., Dubeau, F., Andermann, F., & Arnold, D. L. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<568::aid-ana4>3.0.co;2-p · Cited by 274
Fine-tuning neuromodulation by adenosine
Sebastião, A. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01517-0 · Cited by 273
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity
Maenhaut, C., Van Sande, J., Libert, F., Abramowicz, M., Parmentier, M., Vanderhaegen, J.-J., Dumont, J. E., Vassart, G., & Schiffmann, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80909-x · Cited by 271
An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons
Scammell, T. E., Gerashchenko, D. Y., Mochizuki, T., McCarthy, M. T., Estabrooke, I. V., Sears, C. A., Saper, C. B., Urade, Y., & Hayaishi, O. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00383-9 · Cited by 269
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., von Lubitz, D. K. J. E., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263
Self-citationCunha, R. A., Vizi, E. S., Ribeiro, J. A., & Sebastião, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052180.x · Cited by 260
Self-citationCell surface adenosine deaminase: Much more than an ectoenzyme
Franco, R., Casadó, V., Ciruela, F., Saura, C., Mallol, J., Canela, E. I., & Lluis, C. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00013-0 · Cited by 257
Rajagopal, R., Chen, Z.-Y., Lee, F. S., & Chao, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0010-04.2004 · Cited by 257
Chen, J.-F., Moratalla, R., Impagnatiello, F., Grandy, D. K., Cuellar, B., Rubinstein, M., Beilstein, M. A., Hackett, E., Fink, J. S., Low, M. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1970 · Cited by 256
Self-citationThe type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference
Choi, D.-S., Cascini, M.-G., Mailliard, W., Young, H., Paredes, P., McMahon, T., Diamond, I., Bonci, A., & Messing, R. O. (2004) · Nature Neuroscience · doi:10.1038/nn1288 · Cited by 255
Purinergic approaches in experimental therapeutics
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)82766-3 · Cited by 255
Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 254
Self-citationAdenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
Schiffmann, S., & Vanderhaeghen, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01080.1993 · Cited by 251
Adenosine analogs and sleep in rats.
Radulovacki, M., Virus, R. M., Djuricic-Nedelson, M., & Green, R. D. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21636-6 · Cited by 250
Antiparkinsonian effect of a new selective adenosine A2Areceptor antagonist in MPTP-treated monkeys
Grondin, R., Bédard, P. J., Tahar, A. H., Grégoire, L., Mori, A., & Kase, H. (1999) · Neurology · doi:10.1212/wnl.52.8.1673 · Cited by 249
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248
Adenosine-dopamine interactions in the ventral striatum
Ferré, S. (1997) · Psychopharmacology · doi:10.1007/s002130050380 · Cited by 248
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7350 · Cited by 248
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
Hutchison, A. J., Webb, R. L., Oei, H. H., Ghai, G. R., Zimmerman, M. B., & Williams, M. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20735-2 · Cited by 245
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
Bruns, R. F., & Fergus, J. H. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09591-4 · Cited by 244
Involvement of astrocytes in purine‐mediated reparative processes in the brain
Ciccarelli, R., Ballerini, P., Sabatino, G., Rathbone, M. P., D'Onofrio, M., Caciagli, F., & Di Iorio, P. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00084-8 · Cited by 241
Caffeine — an atypical drug of dependence
Daly, J. W., & Fredholm, B. B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00077-5 · Cited by 240
Self-citationCloning and expression of an A1 adenosine receptor from rat brain.
Mahan, L. C., McVittie, L. D., Smyk-Randall, E. M., Nakata, H., Monsma, F. J., Gerfen, C. R., & Sibley, D. R. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12833-2 · Cited by 238
Amplification of dopaminergic signaling by a positive feedback loop
Nishi, A., Bibb, J. A., Snyder, G. L., Higashi, H., Nairn, A. C., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220410397 · Cited by 238
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
Cha, J.-H. J., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., Penney, J. B., Davies, S. W., Bates, G. P., & Young, A. B. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0449 · Cited by 238
Porkka-Heiskanen, T., Alanko, L., Kalinchuk, A., & Stenberg, D. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0201 · Cited by 236
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
The electrophysiology of adenosine in the mammalian central nervous system
Greene, R. W., & Haas, H. L. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90005-l · Cited by 233
Heteromeric association creates a P2Y-like adenosine receptor
Yoshioka, K., Saitoh, O., & Nakata, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121587098 · Cited by 231
Svenningsson, P., Hall, H., Sedvall, G., & Fredholm, B. B. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<322::aid-syn6>3.0.co;2-e · Cited by 230
Self-citationBenington, J. H., Kodali, S. K., & Heller, H. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00590-m · Cited by 228
Bonci, A., & Williams, J. T. (1996) · Neuron · doi:10.1016/s0896-6273(00)80082-3 · Cited by 228
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors
Fiebich, B. L., Biber, K., Lieb, K., Van Calker, D., Berger, M., Bauer, J., & Gebicke-Haerter, P. J. (1996) · Glia · doi:10.1002/(sici)1098-1136(199610)18:2<152::aid-glia7>3.0.co;2-2 · Cited by 225
Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease
Ikeda, K., Kurokawa, M., Aoyama, S., & Kuwana, Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00694.x · Cited by 224
Corset, V., Nguyen-Ba-Charvet, K. T., Forcet, C., Moyse, E., Chédotal, A., & Mehlen, P. (2000) · Nature · doi:10.1038/35037600 · Cited by 223
Endogenously Released Adenosine Regulates Excitability in the In Vitro Hippocampus
Dunwiddie, T. V. (1980) · Epilepsia · doi:10.1111/j.1528-1157.1980.tb04305.x · Cited by 222
Lopes, L. V., Cunha, R. A., Kull, B., Fredholm, B. B., & Ribeiro, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00080-5 · Cited by 222
Self-citationPopoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi-Albedi, F., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218
Chapter 11 Adenosine and Neuroprotection
Fredholm, B. B. (1996) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60723-0 · Cited by 217
Self-citationCunha, R. A., Sebastião, A. M., & Ribeiro, J. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01987.1998 · Cited by 217
Self-citationBindingDB (2012) · PubMed · doi:10.7270/q2m9077b · Cited by 216
Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K., & Kuwana, Y. (1999) · Psychopharmacology · doi:10.1007/s002130051146 · Cited by 216
BALLARÍN, M., FREDHOLM, B. B., AMBROSIO, S., & MAHY, N. (1991) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1991.tb09133.x · Cited by 214
Self-citationRole of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat
Portas, C. M., Thakkar, M., Rainnie, D. G., Greene, R. W., & McCarley, R. W. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00640-9 · Cited by 208
Mogul, D. J., Adams, M. E., & Fox, A. P. (1993) · Neuron · doi:10.1016/0896-6273(93)90322-i · Cited by 206
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy
Huber, A., Padrun, V., Déglon, N., Aebischer, P., Möhler, H., & Boison, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131102898 · Cited by 205
Bibbiani, F., Oh, J. D., Petzer, J. P., Castagnoli, N., Chen, J.-F., Schwarzschild, M. A., & Chase, T. N. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00250-4 · Cited by 204
Self-citationLinden, J., Taylor, H. E., Robeva, A. S., Tucker, A. L., Stehle, J. H., Rivkees, S. A., Fink, J. S., & Reppert, S. M. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13220-3 · Cited by 204
Winn, H. R., Welsh, J. E., Rubio, R., & Berne, R. M. (1980) · Circulation Research · doi:10.1161/01.res.47.4.568 · Cited by 202
Rivkees, S. A., Price, S. L., & Zhou, F. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00062-u · Cited by 201
Auchampach, J. A., Jin, X., Wan, T. C., Caughey, G. H., & Linden, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.846 · Cited by 201
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00034 · Cited by 200
Yacoubi, M. E., Ledent, C., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J., & Vaugeois, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704240 · Cited by 199
Self-citationMartinez-Mir, M. I., Probst, A., & Palacios, J. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90038-p · Cited by 198
Mitchell, J., Lupica, C., & Dunwiddie, T. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03439.1993 · Cited by 196
Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1856 · Cited by 196
Self-citationRodrigues, R. J., Alfaro, T. M., Rebola, N., Oliveira, C. R., & Cunha, R. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02887.x · Cited by 196
Self-citationAdenosine A2AReceptors are Colocalized with and Activate Golfin Rat Striatum
Kull, B., Svenningsson, P., & Fredholm, B. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.771 · Cited by 196
Self-citationJoseph, S. M., Buchakjian, M. R., & Dubyak, G. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302680200 · Cited by 196
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.
Abbracchio, M. P., Brambilla, R., Ceruti, S., Kim, H. O., von Lubitz, D. K., Jacobson, K. A., & Cattabeni, F. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10571-3 · Cited by 195
Increased Sensitivity to Caffeine in Patients With Panic Disorders: Preliminary Evidence
Boulenger, J.-P. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220057009 · Cited by 193
Lopes, L. V., Cunha, R. A., & Ribeiro, J. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3196 · Cited by 191
Self-citationThe role of receptor structure in determining adenosine receptor activity
Olah, M. E., & Stiles, G. L. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00051-0 · Cited by 191
The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.
Libert, F., Schiffmann, S. N., Lefort, A., Parmentier, M., Gérard, C., Dumont, J. E., Vanderhaeghen, J. J., & Vassart, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07691.x · Cited by 190
Schulte, G., & Fredholm, B. B. (2000) · PubMed · Cited by 188
Self-citationComparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
Ongini, E., Dionisotti, S., Gessi, S., Irenius, E., & Fredholm, B. B. (1999) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005326 · Cited by 187
Self-citationPurinergic mechanisms in epilepsy
Dragunow, M. (1988) · Progress in Neurobiology · doi:10.1016/0301-0082(88)90028-7 · Cited by 187
Pharmacology of adenosine receptors in the vasculature
Tabrizchi, R., & Bedi, S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00152-8 · Cited by 187
Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., & Caciagli, F. (1999) · Glia · doi:10.1002/(sici)1098-1136(199909)27:3<275::aid-glia9>3.0.co;2-0 · Cited by 187
Acquas, E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00290-7 · Cited by 186
Huston, J. P., Haas, H. L., Boix, F., Pfister, M., Decking, U., Schrader, J., & Schwarting, R. K. W. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00021-8 · Cited by 184
Cunha, R. A., Constantino, M. D., Sebasti�o, A. M., Johansson, B., & Fredholm, B. B. (1996) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00168627 · Cited by 184
Self-citationAdenosine in the Nervous System
(1991) · Elsevier eBooks · doi:10.1016/c2009-0-02631-2 · Cited by 180
Aoyama, S., Kase, H., & Borrelli, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05848.2000 · Cited by 180
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A. A., Bibb, J. A., Fredholm, B. B., Nairn, A. C., Greengard, P., & Fisone, G. (2002) · Nature · doi:10.1038/nature00817 · Cited by 180
Self-citationThe HIV-1 Reverse Transcription (RT) Process as Target for RT Inhibitors
Jonckheere, H., Anné, J., & Clercq, E. D. (2000) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(200003)20:2<103::aid-med1>3.0.co;2-x · Cited by 180
Ciruela, F., Escriche, M., Burgueño, J., Angulo, E., Casadó, V., Soloviev, M. M., Canela, E. I., Mallol, J., Chan, W.-Y., Lluis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006960200 · Cited by 180
Giménez‐Llort, L., Fernández‐Teruel, A., Escorihuela, R. M., Fredholm, B. B., Tobeña, A., Pekny, M., & Johansson, B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02122.x · Cited by 179
Self-citationAngulo, E., Casadó, V., Mallol, J., Canela, E. I., Viñals, F., Ferrer, I., Lluis, C., & Franco, R. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00475.x · Cited by 178
Svenningsson, P., Nomikos, G. G., & Fredholm, B. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04011.1999 · Cited by 177
Self-citationAgonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
Kim, Y.-C., Ji, X.-D., Melman, N., Linden, J., & Jacobson, K. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990421v · Cited by 176
A2Aadenosine receptor-mediated inhibition of renal injury and neutrophil adhesion
Okusa, M. D., Linden, J., Huang, L., Rieger, J. M., Macdonald, T. L., & Huynh, L. P. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f809 · Cited by 175
Dunwiddie, T. V., Diao, L., Kim, H. O., Jiang, J.-L., & Jacobson, K. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00607.1997 · Cited by 173
Diógenes, M. J., Fernandes, C. C., Sebastião, A. M., & Ribeiro, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4454-03.2004 · Cited by 172
Distribution of adenosine A2 receptor mRNA in the human brain
Schiffmann, S. N., Libert, F., Vassart, G., & Vanderhaeghen, J.-J. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90391-6 · Cited by 172
Molecular characterization of a human brain adenosine A2 receptor
Furlong, T. J., Pierce, K. D., SELBIE, L. A., & Shine, J. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90152-2 · Cited by 170
Thakkar, M. M., Winston, S., & McCarley, R. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04278.2003 · Cited by 169
Alam, M. N., Szymusiak, R., Gong, H., King, J., & McGinty, D. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00679.x · Cited by 169
The selective vulnerability of striatopallidal neurons
Mitchell, I. J., Cooper, A. J., & Griffiths, M. R. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00019-2 · Cited by 168
Lundblad, M., Vaudano, E., & Cenci, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01632.x · Cited by 168
Dunwiddie, T. V., & Diao, L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38968-8 · Cited by 168
Rebola, N., Pinheiro, P. C., Oliveira, C. R., Malva, J. O., & Cunha, R. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03247-5 · Cited by 165
Self-citationSatoh, S., Matsumura, H., Suzuki, F., & Hayaishi, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5980 · Cited by 165
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Astrocytic complexity distinguishes the human brain
Oberheim, N. A., Wang, X., Goldman, S., & Nedergaard, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.004 · Cited by 739
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
Metadata
- Authors
- Fredholm, B. B., Chen, J.-F., Cunha, R. A., Svenningsson, P., & Vaugeois, J.-M.
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2005
- Volume
- 63
- Pages
- 191-270
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W1576503935
- Cited by
- 692
- References
- 473
- FWCI
- 26.42
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.